Cartalax (Ala-Glu-Asp) is a synthetic tripeptide bioregulator studied for regenerative effects on cartilage and connective tissue. Belongs to the Khavinson family of short peptide bioregulators.

📊Clinical Studies & Results

Cartalax belongs to the Khavinson short peptide bioregulator family.

▪Stimulates chondrocyte proliferation in vitro
▪Supports ECM synthesis in cartilage models
▪Published bioregulator research series

Cartalax is a research tripeptide with documented cartilage regeneration properties.

🏆Benefits

Stimulates chondrocyte proliferation
Supports cartilage extracellular matrix synthesis
Studied in osteoarthritis models
Low immunogenicity bioregulator class

⚠️Possible Side Effects

▪Generally well tolerated
▪Rare injection-site reaction
▪Limited long-term safety data

🎯Ideal For

→Cartilage regeneration research
→Joint health models
→Connective tissue repair
→Bioregulator research

LABORATORY REAGENT – FOR RESEARCH PURPOSES ONLY

This product is not a drug or food and should be handled by qualified professionals in laboratory conditions. All product information is provided for educational purposes only.

Description

Information:

The product (substance) isn't a food or diet supplement and is not suitable for human consumption.
Keep out of children's reach
Keep container tightly closed.
Store in a dry, cool and shaded place; protect from moisture.
Store only in the original container.
Avoid contact during pregnancy and breast feeding.
Consult a doctor in the event of feeling unwell or having adverse effects related to the contact with the substance.